Table 3 Segmentation performances for patients with residual tumor, for both architectures, all input configurations, and over the validation and test sets.

Input	Prot.	Arch.	Voxel-wise		Patient-wise
Input	Prot.	Arch.	DSC-P	DSC-TP	Recall	Precision	HD95 (mm)	mAVE (ml)
A	Val	nnU-Net	46.94±24.03	49.51±21.70	94.42±6.69	62.96±6.60	37.55±32.40	0.97
	Val	AGU-Net	37.72±29.54	51.05±22.28	74.10±7.57	80.75±5.79	18.05±17.99	0.76
	Test	nnU-Net	52.38±21.14	53.43±19.77	98.04	70.83	22.99±32.03	1.49
	Test	AGU-Net	38.06±27.45	46.21±22.80	82.35	84.31	21.55±33.40	1.37
B	Val	nnU-Net	52.97±22.66	55.62±19.63	95.08±5.73	66.82±6.06	29.02±31.02	0.51
	Val	AGU-Net	39.71±28.25	51.54±20.59	77.15±7.14	82.30±4.60	16.84±18.09	0.65
	Test	nnU-Net	59.19±20.49	61.61±16.72	96.08	80.65	22.56±33.25	0.57
	Test	AGU-Net	43.76±27.61	53.14±20.23	82.35	87.76	21.28±35.39	0.89
C	Val	nnU-Net	52.43±22.45	54.72±19.77	95.55±7.10	63.70±6.68	35.82±35.02	0.60
	Val	AGU-Net	37.43±28.69	51.09±20.49	73.23±10.68	84.70±3.23	18.76±19.78	0.62
	Test	nnU-Net	58.14±21.01	60.51±17.52	96.08	76.12	25.43±35.27	0.55
	Test	AGU-Net	42.33±27.87	53.97±18.51	78.43	95.24	20.73±36.04	0.55
D	Val	nnU-Net	52.80±22.59	55.26±19.73	95.35±6.40	66.21±5.72	25.08±28.91	0.48
	Val	AGU-Net	41.02±28.08	52.45±20.14	78.28±6.25	85.16±5.24	15.87±16.62	0.55
	Test	nnU-Net	58.05±22.74	60.42±19.61	96.08	79.69	21.23±33.67	0.34
	Test	AGU-Net	40.84±28.62	52.07±20.96	78.43	93.02	19.97±26.64	0.69
E	Val	nnU-Net	53.61±22.57	55.81±19.97	95.86±6.38	63.86±6.93	29.47±31.84	0.64
	Val	AGU-Net	39.44±27.05	48.89±20.92	80.67±5.71	84.58±3.39	16.36±15.42	0.73
	Test	nnU-Net	56.30±21.07	58.60±17.84	96.08	76.12	19.50±30.01	0.69
	Test	AGU-Net	41.23±25.72	47.78±20.93	86.27	89.80	21.38±35.04	1.11

Quick links

Search